AI blood test could spot hidden cancer before scans
NCT ID NCT07189520
Summary
This study is testing a new artificial intelligence tool designed to detect leftover cancer cells after treatment and better predict if rectal cancer might return. The AI combines information from blood tests, scans, and medical records to look for early warning signs that current methods might miss. Researchers aim to improve early detection of returning cancer by at least 20% compared to standard approaches.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RECTAL CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.